Abstract 4156: BI-1808 - a first in class ligand-blocking αTNFR2 antibody for cancer immunotherapy
Mårtensson, Linda, Cleary, Kirsty, Holmkvist, Petra, Kovacek, Mathilda, Svensson, Carolin, Semmrich, Monika, Blidberg, Therese, Demiri, Mimoza, Dadas, Osman, Borggren, Marie, Pitic, Vici, Lim, Sean H., Beers, Stephen A., Gertsson, Susanne, Rohrberg, Kristoffer S., Karlsson, Ingrid, McAllister, Andres, Cragg, Mark S., Frendeus, Björn, Teige, Ingrid
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article